Yoshiko Stowell

Head of Regulatory Affairs at Neuron23

Yoshiko Stowell, PhD has a diverse work experience in the field of regulatory affairs. Yoshiko'smost recent position is as the Head of Regulatory Affairs at Neuron23 since May 2023. Prior to that, they were the Vice President of Regulatory Affairs and Quality Assurance, as well as the Head of Research and Operations at AmyriAD Therapeutics from January 2023 to May 2023. Yoshiko also served as the Vice President of Regulatory Affairs at the same organization from March 2022 to January 2023.

Before their time at AmyriAD Therapeutics, Yoshiko was the Senior Director of Regulatory Affairs at Eidos Therapeutics from October 2020 to March 2022. Yoshiko also worked at Impax Laboratories from March 2014 to April 2019, where they held the position of Regulatory Affairs Manager.

Yoshiko has also been involved in various leadership roles in professional organizations. Yoshiko was the Chair of the Communication Committee and Co-Chair of the Leaders-Developing-Leaders Committee at Women In Bio - Engage. Educate. Empower. since January 2023. Additionally, they were a member of the San Francisco Bay Area Chapter Leadership Team at the Regulatory Affairs Professionals Society (RAPS) starting from October 2022.

Earlier in their career, Yoshiko worked at Teikoku Pharma USA as an R&D Consultant from August 2011 to March 2014 and as a Project Manager from October 2007 to September 2011. Yoshiko began their career as a Scientist at ALZA Corporation, a subsidiary of Johnson and Johnson, in 2004.

Yoshiko Stowell, PhD, has a strong educational background in the field of pharmaceutical sciences. Yoshiko holds a Doctor of Philosophy (PhD) degree in Pharmaceutical Sciences from the University of the Pacific. Prior to this, they obtained a Master of Science (MS) degree in Chemical Engineering from the University of Oklahoma. Yoshiko also earned a Bachelor of Science (BS) degree in Chemistry from the Tokyo University of Science.

In addition to their academic achievements, Yoshiko has obtained various certifications. In 2022, they completed the Core App certification from Smartsheet. Furthermore, they hold a certification in Project Management Professional, although the specific institution and completion year are unavailable.

Links

Previous companies

Eidos Therapeutics logo

Timeline

  • Head of Regulatory Affairs

    May, 2023 - present

View in org chart